Taxifolin Market: Clear Understanding of The Competitive Landscape and Key Product Segments with Sales and Revenue Insights

Taxifolin, also known as dihydroquercetin, is a class of polyphenol flavonoid discovered in several plants containing anti-inflammatory properties. Studies reveal that taxifolin possesses substantial antibiotic, analgesic and antioxidant properties as well. Therefore, its uptake in pharmaceuticals has registered a massive increase in the past few years.

Taxifolin has shown to have anti-proliferative effects on many types of cancer cells by inhibiting malignant lipogenesis. By inhibiting the fatty acid synthase in cancer cells, taxifolin prevents further growth and spread. This has prompted experts to tout it as a highly effective therapeutic ingredient in anti-cancer drugs.

The multifarious benefits offered by taxifolin also renders it as an important ingredient to enhance the quality and shelf life of food and beverage products. Based on such extensive applications, the taxifolin market is poised to experience positive growth in the future.

“Prominent vendors are actively pursuing R&D activities by collaborating with pharmaceuticals and API manufacturers in order to enhance their market share,” concludes the Fact.MR analyst.

Request a report sample consisting of 170 pages to glean valuable insights at: https://www.factmr.com/connectus/sample?flag=S&rep_id=2801 

Key Takeaways from Fact.MR’s Taxifolin Report

• North America to hold maximum sway by 2030, attributed to extensive usage across the pharmaceutical industry
• Based on purity, the > 95% grade taxifolin appears to be the most lucrative segment
• Exhaustive research to formulate oncology drugs to retain taxifolin interest across the pharmaceuticals segment
• Global taxifolin market is projected to create a value opportunity worth US$ 1.3 Bn, adding nearly twice the value by 2030

Global Taxifolin Market- Prominent Drivers

• Widespread therapeutic effects to heighten incorporation as preservatives across the food & beverage segment, broadening growth prospects
• Burgeoning population and increasing health consciousness to augment demand for taxifolin as supplements
• Increasing usage in antibiotics preparation to multiply revenue prospects in coming years

Global Taxifolin Market- Key Restraints

• Availability of cheaper substitutes such as quercetin may restrain revenue prospects in the upcoming forecast period

COVID-19 Impact Insights

The COVID-19 pandemic has restricted the trade of taxifolin across the global market, disrupting the overall supply chain. Imposition of nationwide lockdowns and restrictions on logistics has led to kinks within production cycles, with output reducing drastically across potential markets.

Disruptions have been especially acute across South Asia & North America, with food & beverage production reducing during Q2 of FY2020. Despite the extensive utilization of taxifolin in pharmaceuticals, the market has declined more than 1.5 fold in the 2^nd quarter of FY2020, and has remained in the same position till the mid-3^rd quarter of FY2020.

However, resumption of beverage & agriculture chemicals production across regions has provided a thrust to the expansion of the taxifolin market size. Therefore, a V-shaped growth curve is anticipated in the remainder of the forecast period.

Request for Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2801

Competitive Landscape

The global taxifolin market is fairly consolidated in nature. JW Health Products, Kingherbs Ltd, Kalenika Group, Ametis JSC, and Abcam plc are among the tier-1 players. According to Fact.MR estimates, together, they are projected to account for more than 45% of the global market share in 2020.

Key manufacturers are observed to be involved in extensive research, product development, and collaborations with pharmaceutical/API manufacturers to enhance their market share. Key companies in the market are involved in conservative market play approach, and are looking to enhance the purity of the product at lower costs.

More Valuable Insights on Taxifolin Market

Fact.MR, in its new offering, presents an unbiased analysis of the global taxifolin market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the taxifolin market on the basis of purity (<95% and ≥95%) and application (food & beverages, pharmaceuticals, healthcare and agriculture), across six major regions (North America, Latin America, Europe Japan, Asia Pacific Excluding Japan, and the Middle East & Africa).

Media Release: https://www.factmr.com/media-release/1653/taxifolin-market-trends

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates